Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300206 · ClinicalTrials.gov registry record
A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System
A clinical trial of Breast Cancer Female, sponsored by Hologic.
- Completed
- Registry status
- 525
- Enrollment target
- 7
- Study locations
NCT03300206: Completed study of Breast Cancer Female, sponsored by Hologic.
NCT03300206 is a study of Breast Cancer Female that has completed, run by Hologic. The registered enrollment target is 525 participants, below the 681-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (23% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03300206, a study of Breast Cancer Female, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- 525 participants
- Enrollment target
- 7
- Study locations
Study Summary
The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current standard-of-care breast biopsy procedures
Primary Outcome
The primary endpoint of this trial is the measured difference in procedure time between biopsies performed with the Brevera biopsy system and those performed with the standard-of-care biopsy systems at each clinical site. Additionally, feedback from the perspective of the participant radiologists, technologists, and subjects using the systems was reported.
Conditions Studied
Interventions
- DEVICE Breast Biopsy
Study Locations (7)
Arizona
- HonorHealth - Phoenix
Maryland
- Kensington Medical Center - Kaiser Permanente - Kensington
Missouri
- Washington University - St Louis
New York
- Elizabeth Wende Breast Center - Rochester
Pennsylvania
- Magee-Womens Hospital of UPMC - Pittsburgh
Texas
- MD Anderson Cancer Center - Houston
Utah
- University of Utah - Huntsman Cancer Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2019-03-19 |
What the finished NCT03300206 record still lists
NCT03300206 is an observational study that tracks outcomes without assigning an intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap, below the 681-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 1 intervention - of which Breast Biopsy is the first listed.
NCT03300206 lists 7 locations in 7 states (Arizona, Maryland, Missouri).
Frequently Asked Questions
What is clinical trial NCT03300206 about?
NCT03300206 is a clinical study titled "A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System". The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System as compared to the current...
What is the current status of trial NCT03300206?
This trial is currently completed. The enrollment target is 525 participants. The study started on 2017-09-13. Estimated completion is 2019-03-19.
What conditions does trial NCT03300206 study?
This clinical trial studies the following conditions: Breast Cancer Female.
What interventions are being tested in trial NCT03300206?
The interventions under investigation include: Breast Biopsy (DEVICE).
Who is sponsoring clinical trial NCT03300206?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03300206 being conducted?
This trial has 7 study locations across Arizona, Maryland, Missouri, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03300206's enrollment target sits among peer trials
525 8th of 46 higher than 39 of 46 other Breast Cancer Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
RECRUITING · Phase 2
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04769492 · 525 participants · NA
#ChopViolence/#ChopHIV
- NCT05260047 · 525 participants · NA
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
- NCT05620719 · 525 participants · NA
Multisite Advancement of Research on Chronic Posttraumatic Headache
- NCT06496646 · 525 participants · NA
Antidepressant Adherence for Depressed Adults in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI